Publication | Closed Access

Dealing with uncertainty and high prices of new medicines: A comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden

Barrier To EntryEconomicsHealth EconomicsManaged Entry AgreementsPharmaceutical PracticeTradeBusinessEconomic AnalysisPharmacoeconomicsCommercial PolicyComparative AnalysisHigh Prices